ICH E6 (R3) introduces a dedicated section on data governance, reflecting the increasing complexity of data sources and ...

Opportunities center on delivering comprehensive GCP training that covers recent regulatory updates, the EU Clinical Trials Regulation, and ICH GCP R3. Interactive courses that address new tech in ...

DUBLIN--(BUSINESS WIRE)--The "GCP (Good Clinical Practice) and Clinical Research Update - Hot Inspection Topics Training Course (May 19, 2026)" training has been added to ResearchAndMarkets.com's ...

Choosing the right EDC (electronic data capture) platform is critical for sponsors, CROs, and clinical operations teams ...

Dear reader, imagine there is a new medicine that could change the lives of thousands of patients in Saudi Arabia, but it remains locked inside reports and scientific ...

We are pleased to communicate that Frontage Europe, a fully owned subsidiary of Frontage Laboratories Inc., has relocated its bioanalytical laboratory to consolidate all services in a 2,500 square ...

EXTON, PA — Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc. (Nasdaq: FHL), has relocated its ...

The performance of clinical trials can be very rewarding for the practicing or academic clinical rheumatologist. There are at least 50 new compounds—small molecules and biologics—in development for ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Credit: Ian Moore / ...

Ryan Eichler holds a B.S.B.A with a concentration in Finance from Boston University. He has held positions in, and has deep experience with, expense auditing, personal finance, real estate, as well as ...

Africa CDC has defined a comprehensive, Africa-relevant checklist of conditionalities that an external company (sponsor) must meet to conduct a vaccine clinical trial in an African country.This ...

Global Healthcare Contract Research Outsourcing Market size is expected to be worth around US$ 100.9 billion by 2033.